Story by Bloomberg May 2024 Covid-19 remained a bigger killer than the flu last winter, despite hopes the pandemic virus would eventually blend into the background with other respiratory germs that cause seasonal epidemics, a US study showed. Patients hospitalised for Covid-19 had a 35 per cent higher risk of dying within 30 days than […]
MAY 14, 2024 – Authored by Joe Wang via The Epoch Times When COVID-19 took the world by storm in early 2020, I mostly relied on reading Nature Medicine, The Lancet, and a few other medical journals to learn the latest on this new disease. In March 2020, I read an article published in Nature […]
MAY 08, 2024 In yet another damning development for the ‘safe and effective’ crowd, AstraZeneca has announced the worldwide withdrawal of its Oxford-AstraZeneca vaccine, branded as Vaxzevria, due to a rare but serious side effect. This decision marks the end of the vaccine once hailed as a “triumph for British science” by Boris Johnson and credited with saving […]
By LUKE ANDREWS SENIOR HEALTH REPORTER FOR DAILYMAIL.COM, 14 May 24 An American woman who took part in the clinical trial for AstraZeneca‘s Covid vaccine is suing the company, claiming the shot left her ‘permanently disabled’. Brianne Dressen, 42 and a former teacher from Utah, volunteered for the study in 2020 to ‘do her part’ and help beat […]
By Jim Hᴏft May. 6, 2024 Just in time for the election… Two new COVID-19 variants, collectively known as “FLiRT,” have been detected and are reportedly spreading across the United States. The FLiRT variants are sub-lineages of the Omicron variant, named for the mutations they bear. The Infectious Disease Society of America states that the nickname ‘FLiRT’ is derived […]
TUESDAY, MAY 07, 2024 – Authored by Naveen Athrappully via The Epoch Times Individuals who took COVID-19 vaccines were found to have later suffered from psychosis, with Pfizer and AstraZeneca shots linked to most of the cases. The peer-reviewed systemic review, published in the Frontiers in Psychiatry journal on April 12, examined cases of new-onset psychosis […]
Fardin Ganjkhanloo, Farzin Ahmadi, Ensheng Dong, Felix Parker, Lauren Gardner, Kimia Ghobadidoi: https://doi.org/10.1101/2024.04.25.24306375 Abstract The COVID-19 pandemic emphasized the need for pandemic preparedness strategies to mitigate its impacts, particularly in the United States, which experienced multiple waves with varying policies, population response, and vaccination effects. This study explores the relationships between county-level factors and COVID-19 mortality outcomes in the U.S. from 2020 to 2023, focusing on […]
Merete Ellingjord-Dale, Anders Nygaard, Nathalie C Støer, et. al. BioRx 05/2024 Abstract Objectives We aimed to describe the trajectories of cognitive and physical symptoms before, during, and after a positive- or negative SARS-CoV-2 test and in untested controls. Design A prospective cohort study. Setting Norway, 27 March 2020 to 6 July 2022 Participants A total of 146 065 volunteers were recruited. Of these, 120 […]
Ingrid Didriksson, Attila Frigyesi, Martin Spångfors, et. al. Abstract Background Long-term outcomes after critical COVID-19 have not been sufficiently studied. This study aimed to describe changes in functional outcome and health-related quality of life (HRQoL) assessed at 3 and 12 months in a cohort of critically ill COVID-19 survivors. A secondary aim was to investigate factors associated with good functional outcome and […]
Grant Stalker, Rosarie Tudas, et. al., doi: https://doi.org/10.1101/2024.04.30.24306497 Abstract Background: Many of those infected with COVID-19 experience long-term disability due to persistent symptoms known as Long-COVID, which include ongoing respiratory issues, loss of taste and smell, and impaired daily functioning. Research Question: This study aims to better understand the chronology of long-COVID symptoms. Study Design and Methods: We prospectively enrolled […]